Growth and Scale Global biotechnology and diagnostics with ISO 9001 and ISO 13485 compliance, and a mid-size team (51-200) suggests readiness for expanded distribution, OEM partnerships, and regional sales channels in Asia-Pacific and beyond.

COVID-19 Momentum Proven track record of rapid response and product launches for SARS-CoV, 2019-nCoV, MERS-CoV and Omicron variant testing, including portable lab-on-chip solutions and extraction-free RT-PCR kits, indicating strong demand for rapid diagnostics and adaptable platforms.

Product Portfolio Diverse offerings across molecular testing, clinical chemistry and point-of-care testing with portable diagnostics and saliva-based sampling; opportunity to cross-sell to hospitals, clinics, and public health labs seeking integrated testing solutions.

Market Positioning Singapore-based, global reach with a focus on quality manufacturing and compliance positions Veredus as a potential partner for distribution agreements, government tenders, and supply contracts in regional markets with stringent regulatory expectations.

Financial Opportunity Revenue in the low-to-mid single digits USD millions aligns with a scalable growth trajectory; potential for channel partnerships, recurring revenue through service and support, and collaborations with larger diagnostic players seeking innovative assay kits.